Conservative politicians like to say they are for free markets, competition, and property rights to promote innovation and lower prices of goods. But when it comes to pharmaceuticals, too many of them go careening off the freedom road to promote socialist policies. They fail to recognize the years of expensive clinical trials and complicated protocols, the thousands of failed prospects that still must be paid for, and the lengthy Food and Drug Administration (FDA) approval process to get just one drug into the marketplace.
